Skip to main content
OpenTrials
Completed

NCT Number: NCT05050552

Oxygen Reserve Index in One-Lung Ventilation During Elective Thoracic Operations

The investigators' goal is to perform an observational cohort study investigating the use of oxygen reserve index (ORi) in patients undergoing elective thoracic surgery and one-lung ventilation (OLV). For this purpose, ORi values are recorded and compared to the other collected hemodynamical and oximeter parameters. The primary hemodynamic parameters include heart rate (HR) and blood pressure (BP), while; oximeter device-related parameters include peripheral oxygen saturation, perfusion index (PI), and pleth variability index (PVI).

The investigators' secondary goal is to investigate relationships between these hemodynamical and oximeter parameters using statistical analysis methods.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Trakya University Training and Research Hospital

Edirne, 22030, Turkey (Türkiye)

About this study

The main objective of this study is to investigate the possible benefits of using the oxygen reserve index (ORi) parameter during one-lung ventilation (OLV) and elective thoracic operations. For this purpose, ORi values are compared to primary hemodynamical parameters of blood pressure (BP) and heart rate (HR) and Meanwhile, a device from Masimo Inc, USA, provides oximeter-related parameters, including peripheral oxygen saturation, perfusion index (PI), and pleth variability index (PVI). The secondary objective is to investigate possible statistically significant correlations between these hemodynamical and oximeter parameters using appropriate statistical methods.

The study participants are patients undergoing video-assisted thoracotomy surgical procedures (VATS) or open thoracotomy for suspicion and possible lung tumor removal. The surgical operation of either lobectomy, pneumonectomy, lung biopsy, or wedge resection is considered during this procedure. The inclusion and exclusion criteria are summarized in another section of the clinicaltrials.gov registration document. All patients in the study receive a similar anesthetic management protocol. Premedication is not required in the study. After admitting a patient to the operating theatre, pulse oximetry SpO2, electrocardiogram, and noninvasive blood pressure monitoring are established. Heart rate (HR), mean arterial pressure (MAP), systolic blood pressure (SBP), and diastolic blood pressure (DBP) are measured at certain time points. Anesthesia requires induction of anesthesia with intravenous doses of propofol (Pofol, Fresenius Pharmaceutical, Turkey), 2 to 3 mg/kg, rocuronium (Esmeron, Organon Pharmaceuticals, U.S.A.) at a dose of 0.6 mg/kg, and fentanyl (Janssen fentanyl, Janssen Pharmaceutical, Belgium) at a dose of 2 to 3 mcg/kg. Tracheal intubation requires the use of a left Robertshaw double-lumen tube. During anesthesia, one-lung ventilation (OLV) is provided to all patients in addition to mechanical ventilation. The anesthesia maintenance includes inhalational anesthetic of sevoflurane (Sevorane, Abbott Pharmaceutical, USA) at an end-tidal concentration of 1 to 2% to provide a sufficient minimum alveolar concentration to establish anesthesia and intravenous fentanyl boluses at a dose of 0.2 mcg/kg every hourly to provide analgesia and to keep mean arterial blood pressure between 60 and 80 mmHg. In addition to standard follow-up parameters, oxygen reserve index (ORi), perfusion index (PI), pleth variability index (PVI) is monitored for each patient at certain time points. Hypoxemia during OLV was defined as peripheral oxygen saturation (SpO2) value of less than 95% when the inspired oxygen fraction (FiO2)value is equal to or greater than 60% on a pulse oximetry device. Hemodynamic and oximeter data were continuously monitored. The parameters that are in need of investigation include; MAP, SBP, DBP, HR, SpO2, PaO2, ORi, PI, and PVI values. These data are monitored at thirteen different time points during the period of anesthesia induction and maintenance of the surgery. The device used in this study is called the Radical-7 Pulse CO-Oximeter device for the measurement of ORi, PI, and PVI. A correlation between these values was investigated on the continuous graphs. The duration of surgery, anesthesia, OLV, and total 100% oxygen application time are recorded. Blood gas analysis was provided at DL5 at a 5-minute time point and blood gas analysis was performed for prolonged surgeries and for surgeries with high bleeding performance that required other analysis. Routinely, patients are ventilated with 50% FiO2 (50% oxygen + 50% air mixture, 1 liter/minute fresh gas flow) after induction. The value of FiO2 rises depending on pulse oximeter values between the values of 60% and 100% in order to keep SpO2 values greater than 94. The incidence of thromboembolic complications, arrhythmia, pneumonia, the duration of hospital and intensive care unit stay is recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients at ages between 22 to 80 years old,
  • American Society of Anesthesiologists Physical Status (ASA-PS) risk groups of 1 to 3
  • Elective thoracic surgery
  • Operational types of thoracic surgery include; either open lung resection with thoracotomy or video-assisted thoracic surgery (VATS) operative procedure along with general a anesthesia, DLT insertion, and OLV for all patients

Exclusion criteria

  • Refusal to participate in a study,
  • History of severe asthma,
  • Severe renal and hepatic insufficiencies,
  • Pregnancy,
  • History of previous pulmonary resection,
  • Hemoglobinopathies.

Treatment and study plan

Masimo Radical-7 Pulse CO-Oximeter

Device

The Masimo Radical-7 Pulse CO-Oximeter is a device for the measurement of pulse oximetry, oxygen reserve index (ORi), perfusion index (PI), and pleth variability index (PVI). The device is the product of a company called Masimo Inc, Irvine, CA, USA

Primary outcomes

  1. Main Outcome Measure-(1)

    Time frame: Baseline time point after patient's arrival into operating room before anesthesia induction during elective thoracic operation

    Baseline time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  2. Main Outcome Measure-(2)

    Time frame: Preoxygenation time point before anesthesia induction during elective thoracic operation

    Preoxygenatiom time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  3. Main Outcome Measure-(3)

    Time frame: Third time point during thoracic operation defined as; five minutes after tracheal intubation during two-lung ventilation in the supine position during elective thoracic operation

    Third time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  4. Main Outcome Measure-(4)

    Time frame: Fourth time point during thoracic operation defined as; 5 minutes after placing the patient in a lateral position with two-lung ventilation during elective thoracic operation

    Fourth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  5. Main Outcome Measure-(5)

    Time frame: Fifth time point during thoracic operation defined as; at 1 minute after OLV placement during elective thoracic operation

    Fifth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  6. Main Outcome Measure-(6)

    Time frame: Sixth time point during thoracic operation defined as; at 2 minute after OLV placement during elective thoracic operation.

    Sixth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  7. Main Outcome Measure-(7)

    Time frame: Seventh time point during thoracic operation defined as; at 5 minute after OLV placement during elective thoracic operation.

    Seventh time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  8. Main Outcome Measure-(8)

    Time frame: Eighth time point during thoracic operation defined as; at 10 minute after OLV placement during elective thoracic operation.

    Eighth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  9. Main Outcome Measure-(9)

    Time frame: Ninth time point during thoracic operation defined as; at 15 minute after OLV placement during elective thoracic operation.

    Ninth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  10. Main Outcome Measure-(10)

    Time frame: Tenth time point during thoracic operation defined as; at 30 minute after OLV placement during elective thoracic operation.

    Tenth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  11. Main Outcome Measure-(11)

    Time frame: Eleventh time point during thoracic operation defined as; at 45 minute after OLV placement during elective thoracic operation.

    Eleventh time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  12. Main Outcome Measure-(12)

    Time frame: Twelfth time point during thoracic operation defined as; at 60 minute after OLV placement during elective thoracic operation.

    Twelfth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

  13. Main Outcome Measure-(13)

    Time frame: Thirteenth time point during thoracic operation defined as; at 90 minute after OLV placement during elective thoracic operation.

    Thirteenth time point measurement of oxygen reserve index (ORi) equals to zero for predicting hypoxemia during one-lung ventilation

Secondary outcomes

  1. Secondary Outcome-(1)

    Time frame: During anesthesia induction and maintenance of elective thoracic operation

    A correlation between ORi and peripheral oxygen saturation (SpO2), ORi and perfusion index (PI), and ORi pleth variability index (PVI) parameters that we collected during operation in patients undergoing elective thoracic surgery and one-lung ventilation (OLV)

  2. Secondary Outcome-(2)

    Time frame: Twenty-four hours prior to elective thoracic surgery operation

    The Patients' demographic parameters and co-morbid diseases

  3. Secondary Outcome-(3)

    Time frame: During elective thoracic surgery every five minutes continuously

    Measurement of mean arterial pressure (MAP)

  4. Secondary Outcome-(4)

    Time frame: During elective thoracic surgery every five minutes continuously

    Measurement of systolic blood pressure (SBP)

  5. Secondary Outcome-(5)

    Time frame: During elective thoracic surgery every five minutes continuously

    Measurement of diastolic blood pressure (DBP)

  6. Secondary Outcome-(6)

    Time frame: During elective thoracic surgery every five minutes continuously

    Measurement of heart rate (HR)

  7. Secondary Outcome-(7)

    Time frame: Five minutes after placing the patient in a lateral position with two-lung ventilation

    Arterial blood gas analysis during elective thoracic surgical operation

Sponsors and collaborators

Lead sponsor

Trakya University

Other

Registry information

Official study title

Oxygen Reserve Index and Its Relations With Primary Hemodynamical and Oximeter Parameters During Elective Thoracic Surgical Operations

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Sep 20, 2021
Registry last updated
Sep 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.